Zeria Pharmaceutical Co., Ltd. Announces the Results From Phase III, Double-Blind, Placebo-Controlled Study of Z-338 for Functional Dyspepsia Conducted in Japan
6/28/2010 12:03:01 PM
More...
|
HemCon Medical Technologies, Inc. and Zeria Pharmaceutical Co., Ltd. Sign Exclusive Licensing Agreement for HemCon’s Innovative Product Line in Japan
4/9/2010 8:57:15 AM
More...
|
Zeria Pharmaceutical Co., Ltd. Licenses Gastric Ulcer Drug To SK Chemicals Co. Ltd.
3/3/2006 10:58:37 AM
More...
|
InKine Pharmaceutical Company, Inc. (INKP) Earns Milestone Payment As Zeria Pharmaceutical Co., Ltd. Advances Development Of Tablet Purgative -Visicol- For Sale In Japan
10/19/2005 5:13:09 PM
More...
|
Zeria Pharmaceutical Co., Ltd. Brings Nizatidine-Based OTC Gastrointestinal Drug To Market
10/19/2005 5:09:01 PM
More...
|